Healthcare provider profile · identity verified

Todd Motley, M.D.

Internal Medicine · MEMPHIS, TN · NPI 1184675332

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	851	266
Amlodipine Besylate	Amlodipine Besylate	697	217
Furosemide	Furosemide	391	123
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	365	104
Carvedilol	Carvedilol	353	101
Omeprazole	Omeprazole	335	102
Zolpidem Tartrate	Zolpidem Tartrate	320	52
Metformin Hcl	Metformin Hcl	299	90
Hydralazine Hcl	Hydralazine Hcl	252	83
Gabapentin	Gabapentin	232	58
Potassium Chloride	Potassium Chloride	225	70
Olmesartan Medoxomil	Olmesartan Medoxomil	221	71
Vitamin D2	Ergocalciferol (Vitamin D2)	209	59
Meloxicam	Meloxicam	196	61
Metoprolol Tartrate	Metoprolol Tartrate	179	65
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	179	54
Tamsulosin Hcl	Tamsulosin Hcl	171	55
Jardiance	Empagliflozin	168	40
Allopurinol	Allopurinol	164	51
Albuterol Sulfate Hfa	Albuterol Sulfate	160	37
Simvastatin	Simvastatin	160	39
Hydrochlorothiazide	Hydrochlorothiazide	156	49
Farxiga	Dapagliflozin Propanediol	153	43
Minoxidil	Minoxidil	153	60
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	153	48
Nifedipine Er	Nifedipine	147	45
Glimepiride	Glimepiride	143	51
Pantoprazole Sodium	Pantoprazole Sodium	137	41
Clopidogrel	Clopidogrel Bisulfate	127	40
Diclofenac Sodium	Diclofenac Sodium	126	37
Lisinopril	Lisinopril	123	36
Rosuvastatin Calcium	Rosuvastatin Calcium	123	36
Valsartan	Valsartan	119	38
Levothyroxine Sodium	Levothyroxine Sodium	113	29
Pioglitazone Hcl	Pioglitazone Hcl	112	34
Januvia	Sitagliptin Phosphate	110	20
Atenolol	Atenolol	103	28
Ozempic	Semaglutide	102	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	96	29
Eliquis	Apixaban	96	25
Ibuprofen	Ibuprofen	96	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	94	32
Finasteride	Finasteride	90	32
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	88	26
Clonidine Hcl	Clonidine Hcl	87	22
Myrbetriq	Mirabegron	78	21
Metoprolol Succinate	Metoprolol Succinate	74	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	19
Megestrol Acetate	Megestrol Acetate	69	25
Lorazepam	Lorazepam	68	13
Escitalopram Oxalate	Escitalopram Oxalate	66	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	66	19
Indapamide	Indapamide	65	18
Linzess	Linaclotide	64	18
Testosterone Cypionate	Testosterone Cypionate	61	16
Trazodone Hcl	Trazodone Hcl	61	suppressed
Meclizine Hcl	Meclizine Hcl	58	22
Pravastatin Sodium	Pravastatin Sodium	57	19
Labetalol Hcl	Labetalol Hcl	56	13
Levetiracetam	Levetiracetam	55	11
Alprazolam	Alprazolam	54	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	18
Gemfibrozil	Gemfibrozil	53	19
Montelukast Sodium	Montelukast Sodium	51	14
Famotidine	Famotidine	49	17
Nebivolol Hcl	Nebivolol Hcl	49	12
Trulicity	Dulaglutide	48	12
Benazepril Hcl	Benazepril Hcl	43	16
Metoclopramide Hcl	Metoclopramide Hcl	43	17
Glipizide	Glipizide	42	suppressed
Ketoconazole	Ketoconazole	42	13
Janumet Xr	Sitagliptin Phos/Metformin Hcl	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	14
Mounjaro	Tirzepatide	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Tresiba Flextouch U-200	Insulin Degludec	37	14
Bupropion Xl	Bupropion Hcl	36	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	12
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	33	suppressed
Halobetasol Propionate	Halobetasol Propionate	33	14
Losartan Potassium	Losartan Potassium	32	11
Pregabalin	Pregabalin	32	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	32	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	29	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	29	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	23
Donepezil Hcl	Donepezil Hcl	28	11
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Repatha Sureclick	Evolocumab	27	suppressed
Colchicine	Colchicine	26	12
Methimazole	Methimazole	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Xarelto	Rivaroxaban	25	11
Klor-Con M20	Potassium Chloride	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Etodolac	Etodolac	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Prednisone	Prednisone	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Breyna	Budesonide/Formoterol Fumarate	21	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	21	suppressed
Mometasone Furoate	Mometasone Furoate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Levofloxacin	Levofloxacin	17	17
Promethazine Hcl	Promethazine Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Bystolic	Nebivolol Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	16
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Azor	Amlodipine Bes/Olmesartan Med	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Risperidone	Risperidone	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Livalo	Pitavastatin Calcium	13	suppressed
Metolazone	Metolazone	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error